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Introduction 
 
The Sanger method (Sanger, Nicklen & Coulson 1977) has been the golden standard for 
DNA sequencing for the last few decades. It has played a major role in understanding 
genomic sequence in human (Lander et al 2001, Venter et al 2001) and other species 
such as Escherichia coli (Blattner et al. 1997) and hence has substantially contributed to 
the studies of medicine and biotechnology. The growing interest for sequencing with 
higher throughput and lower costs in the last decade has led to development of new 
sequencing applications. The currently leading platforms are Genome Analyzer (Illumina 
Inc., San Diego, CA, USA), Solid (Applied Biosystems, Foster City, CA, USA) and 454 
(454 Life Sciences, a Roche company, Branford, CT, USA). Each platform is based on 
specific technological innovations (Margulies et al. 2005, Bentley et al. 2008, Fedurco et 
al. 2006, Shendure et al. 2005). On the other hand all of them rely on high quality nucleic 
acid libraries. 
 
The main weakness of current library preparation protocols is that they have not been 
optimized for the variation between samples. The amplification, for example, is often 
performed blindfolded without a prior knowledge of the sample concentration. This 
creates fluctuation between samples and complicates possible troubleshooting. The 
presence of primers dimers hinders the accuracy of quantification and should thus be 
avoided. The purification methods used in current protocols are not efficient enough for 
this and other methods should be looked into. The quantification for sequencing should 
be repeatable and precise in order to maximize the data yield. At the moment there are no 
guidelines for quantification method from the manufacturers thus creating the need for 
optimization. (Appendix 2) 
 
This Master’s thesis concentrates on optimizing DNA library preparation for Illumina 
Genome Analyzer II sequencer with the amount of sample sufficient for sequence 
capture. However, the sample library steps described here are  partially adaptable also for 
454 and Solid. 
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Sequencing with Genome Analyzer II 
 
The genome Analyzer II workflow consists of sample preparation, cluster amplification, 
sequencing and data analysis. 
 
Sample preparation 
 
 
Figure 1 Sample preparation workflow. In sample preparation DNA is fragmented, end repaired, A-
tailed, ligated and amplified. (Adapted from “Go where biology takes you” brochure, http://www.illumina.com, 
Publication Number 770-2009-034)  
 
Genome Analyzer II can utilize nucleic acids from various resources if it is provided in a 
compatible format (de Magalhães, Finch & Janssens 2010, Schmidt et al. 2009, 
Linnarsson 2010). The library consists of short fragments of double-stranded DNA. 
These fragments should be approximately 150 to 500 base pairs long to have uniform 
performance in cluster amplification. The fragments have adapters on both ends of the 
fragment complementary to both adapters on flow cell and sequencing primers 
(Linnarsson 2010, Pettersson, Lundeberg & Ahmadian 2009, Mardis 2008).  
 
The primary step in standard library preparation protocol is fragmentation in which the 
genomic DNA is sheared to short fragments of double-stranded DNA. The fragments that 
have single-stranded overhangs at this point are then end repaired to generate blunt-
ended fragments. The addition of deoxyadenosine monophosphate (dAMP) to the 3’-end 
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of the strands enhances the efficiency of the correct ligation (Linnarsson 2010). The 
polymerase chain reaction (PCR) amplification is also needed in order to enrich the 
fragments that have been successfully prepared and thus have the adapters in both ends 
and are capable of amplifying and attaching to a flow cell. (Figure 1) 
 
Fragmentation 
 
The fragmentation can be performed either by mechanical or sonar force or by enzymatic 
reaction. The official Illumina sample preparation protocol uses pressurized air based 
method called nebulization to fragment the DNA. Other means for fragmentation are 
focused sonication (Covaris Inc., Woburn, MA, USA) and enzymatic fragmentation with 
Fragmentase (New England Biolabs, Ipswich, MA, USA). In enzymatic fragmentation 
random nicks are created by nuclease and the nicks are recognized by endonuclease 
which cleaves the other strand (New England Biolabs 2010). Also DNaseI in the 
presence of Mn2+ fragments the DNA (Linnarsson 2010). 
 
Sample yields from focused sonication can be more than four-fold compared to 
nebulization since the fragment size distribution is narrower. The enzymatic methods 
have wider size distribution than sonication but have better yields than nebulization 
(Linnarsson 2010). 
 
End repair 
 
After the fragmentation the fragments have 3’ and 5’ overhangs which must be cut off in 
order to have blunt-ended fragments which can be further prepared for adapter ligation. 
T4 DNA polymerase catalyzes the synthesis of DNA in the 5’ -> 3’ direction thus filling 
the 5’ overhangs and cleaves the 3’ overhangs with its 3’ -> 5’ exonuclease activity 
(Orkin 1990).  
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 A-tailing 
 
The aim of incorporating deoxyadenosine monophosphate (dAMP) to the 3’ end of the 
blunt-ended DNA fragment is to prevent the formation of concatemers in ligation and to 
enhance the ligation efficiency. The adapters have complementary deoxythymidine 
monophosphate (dTMP) in the 3’ end of the ligating end of the adapter which enables 
successful ligation of the adapter. The deoxyadenosine triphosphates (dATP) are 
incorporated by Klenow fragment which is an N-terminal truncation of DNA Polymerase 
I which retains polymerase activity, but has lost the 5´→ 3´ exonuclease activity (Clark, 
Joyce & Beardsley 1987). 
 
Ligation 
 
The ligation process incorporates adapters to both ends of the blunt-ended DNA 
fragments. Successful ligation should result in different adapters in different ends of the 
fragments. A dTMP on the 3’ end of the ligating end of the adapter enables the ligation to 
the DNA fragment with 3’ end dAMP overhang. The DNA strands of the adapters are 
complementary only on the ligating end of the adapter resulting in Y-shape. This 
significantly reduces the formation of fragments with the same adapter in both ends of 
the fragments (Linnarsson 2010). The phosphorotioate modifications in the ends of the 
adapters protect the adapters from endonucleases. The ligation is performed by T4 DNA 
ligase. T4 DNA ligase is an enzyme purified from E. coli C600 pcl857 pPLc28 lig8. It is 
capable of catalyzing the phosphodiester bond formation of juxtaposed 5' phosphate and 
3' hydroxyl termini of DNA and RNA. It can incorporate both blunt-ended and cohesive-
ended termini. (Engler, Richardson 1982)  
 
Purification 
 
After each sample preparation step the library must be purified from salts, enzymes, 
surplus of adapters and other reagents. There are several approaches for purification from 
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which silica-membrane-based method, gel- filtration with resin and paramagnetic bead 
purification are covered in this thesis.  
Silica-membrane purification 
 
DNA in a high-salt buffer binds to silica-gel-membrane. The additional substances are 
removed, and the DNA eluted in a low-salt buffer. This method is susceptible to pH 
changes. (Hamaguchi, Geiduschek 1962, Vogelstein, Gillespie 1979)  
 
Gel filtration with resin 
 
Gel filtration purification utilizes different method compared to the other purification 
approaches. As in other methods DNA is bound to beads or membranes, in gel filtration 
additional substances in the solution are separated from DNA during gel filtration. 
Primers, short single stranded DNA strands, salts, buffers, deoxyribonucleotide 
triphosphates (dNTP) and other small molecules are eluted in larger volume than large 
molecules such as DNA. (EdgeBio 2010) 
 
Paramagnetic bead purification  
 
Solid Phase Reversible Immobilization (SPRI) beads have polystyrene core coated with a 
layer of iron (Figure 2). The iron grants the beads their paramagnetic properties. The 
surface of the bead is a polymer layer containing carboxyl functional groups. The SPRI 
beads bind the negatively charged nucleic acid with the carboxyl groups leaving other 
substances in the solution. The beads carrying the nucleic acid can be separated from the 
solution by external magnetic field. This enables efficient washing and elution of the 
DNA or RNA in proper elution buffer. (Beckman Coulter Genomics 2010, Deangelis, 
Wang & Hawkins 1995) 
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Figure 2 Agencourt AMPure XP SPRI bead. White illustrates the polystyrene core, pink the magnetite 
and purple the polymer layer and the outermost layer contains carboxyl groups. (Adapted from Agencourt 
AMPure SPRI bead brochure, http://www.agencourt.com)  
 
Sequence capture 
 
The next-generation sequencing platforms such as HiSeq 2000 (Illumina) are aiming at 
the whole genome sequencing in a single run of the instrument. However, the Genome 
Analyzer II does not yet have such capacity. This compels to the selection of regions of 
interest and their enrichment in order to keep the sequencing costs and resources in a 
feasible level. At present selected regions of the genome can be captured using 
microarray or a solution phase method. (Mamanova et al. 2010b) Agilent and Roche 
Nimblegen also provide capture probes for the whole human exome. 
 
Array capture 
 
In an array capture application the target specific probes are immobilized on a microarray 
surface. The sample library is hybridized with these probes, nonspecific DNA is washed 
away and the captured DNA is eluted. At present, array capacities varies from 244000 
probes for smaller targets to arrays of 2,1 million probes for exomes. (Mamanova et al. 
2010b, Agilent 2010, Roche NimbleGen 2010) 
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In-solution capture 
 
In an in-solution capture the target regions are captured with biotin attached probes. Of 
the two present in-solution capture manufacturers Agilent uses 150-mer RNA probes and 
Nimblegen 60-90-mer DNA probes (Mamanova et al. 2010b, Gnirke et al. 2009). After 
the hybridization of the probes to the target DNA the captured DNA is separated from 
the non-captured DNA by binding the biotin of the probes to streptavidin coated 
paramagnetic beads. Using external magnetic field the beads and hence the targeted 
regions can be recovered. (Figure 3) (Mamanova et al. 2010b, Invitrogen 2010, Gnirke et 
al. 2009) 
 
Figure 3 Agilent SureSelect Target Enrichment workflow illustrating sequence capture in solution. 
Sample library is hybridized with biotinylated probes and then captured with Streptavidin coated magnetic 
beads and magnet. (Adapted from Agilent SureSelect Target Enrichment protocol, www.chem.agilent.com, 
Publication Number G3360-90010). 
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DNA quantification 
 
Accurate DNA quantification is crucial in sequencing with Illumina Genome Analyzer II. 
If concentration is too high clusters will overlap and the signals from these different 
clusters cannot be distinguished hence resulting in reduced data acquisition. The full 
capacity is not used if the concentration is too low, since the clusters will not be as dense 
as possible (Linnarsson 2010). The raw cluster number, given by the primary data 
analysis of a sequencing experiment, indicates the total cluster number. The purity 
filtered (PF) cluster number is an indicator of the number of clusters that are not 
overlapping (Illumina 2010). 
 
Quantification of DNA is also crucial before sequence capture experiment. A target area 
might not be fully covered if sufficient amount of DNA is not available for capture 
probes. This would result in too few template molecules for amplification after capture 
and creates a risk of producing clonal molecules and a biased library. These clonal 
molecules reduce the data yield of the sequencing run since clonal molecules from 
different clusters are discarded in the data analysis. 
 
Spectrophotometric method 
 
Spectrophotometer measures the absorption of light at different wavelengths. DNA and 
RNA absorbs ultraviolet (UV) light with an absorption peak at 260 nanometers of 
wavelength as proteins have absorption peak at 280 nanometers of wavelength and 
phenol and polysaccharides at 230 nanometers of wavelength. Thus the ratios 260/280 
and 260/230 can be used as an indicator of the purity of the sample. However, the 
260/280 ratio has been noted to be insufficient as an indicator of sample purity since 
even significant protein amounts reduces the ratio only slightly (Linnarsson 2010, Orkin 
1990, Gallagher SR, FAU - Desjardins & Desjardins PR 2008). 
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Spectrophotometer is a rapid method for DNA quantification and NanoDrop instrument 
from Thermo Scientific also reduces the volume needed for the analysis to 1 to 1,5  
microlitres compared to traditional spectrophotometers with analysis volume of 1,5 to 4,5 
millilitres in a cuvette. With NanoDrop the sample is pipetted directly to the pedestal 
hence eliminating the need for cuvettes. (NanoDrop 2010) 
 
The additional primers, adapters and free nucleotides cannot be distinguished from the 
sample library and hence they increase the total concentration. Further since 
spectrophotometrically all nucleic acids are measured also the fragments of the sample 
library that are not able to amplify in flow cell, i.e. lack the adapters from either one or 
both ends, are measured. (Linnarsson 2010) 
 
Microchannel based electrophoresis  
 
Microchannel based electrophoresis platforms (Lab-on-a-chip) such as the 2100 
Bioanalyzer (Agilent, Santa Clara, CA, USA),  are based on fluorescent labeling of the 
sample, electrophoretical separation of the DNA in microfluidic channels (Figure 4) and 
sample analysis and quantification based on internal standards. This method reduces the 
sample volume needed for the analysis and is less time consuming than conventional 
electrophoresis. The advantage of Bioanalyzer compared to other DNA quantification 
methods is the fragment size information which is important in next-generation 
sequencing. Also primers and adapters can be distinguished by their fragment size from 
the sample library while in the other methods these are included in the sample 
concentration. (Kuschel, Buhlmann & Preckel 2005) Bioanalyzer is still unable to 
distinguish the fragments of a sample library that can be sequenced from those than 
cannot (Linnarsson 2010). However, this is not a major issue as the library is amplified  
and the fragments able to be sequenced are enriched from those that are not.  
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Figure 4 Illustration of microchannels on Agilent Bioanalyzer chip. 1. The sample moves through the 
microchannels from the sample well. 2. The sample i s injected into the separation channel. 3. Sample 
components are electrophoretically separated. 4. Components are detected by their fluorescence and translated 
into gel-like images (bands) and electropherograms (peaks). (Adapted from Agilent Bioanalyzer brochure, 
www.chem.agilent.com, Publication Number 5989-7725EN). 
 
Real-time PCR 
 
In real-time qPCR the sample library is amplified with appropriate primers, in this case 
the primers complementary to ends of the library generated in the PCR amplification 
step. The amplification takes place in the presence of SYBR Green I fluorescent dye. 
SYBR Green binds specifically to double-stranded DNA and hence enables the 
quantification of DNA after each cycle of PCR by electron multiplying charge-coupled 
device (CCD). (Finnzymes 2010) Absolute DNA concentration can be achieved by 
comparing the samples with unknown concentration to a dilution series of a sample with 
a known concentration. The dilution series of a known sample will give a standard curve 
where initial sample concentration is plotted against cycle threshold. Plotting the cycle 
thresholds of samples being studied to the standard curve will give the initial 
concentration. (Finnzymes 2010, Sellars et al. 2007) 
 
The benefit of an absolute quantification with real- time PCR compared to the other 
quantification methods is that it simulates the bridge-amplification in sequencing since 
the primers in real-time PCR are the same as the ones attached to flow cell surface in 
which the sample library is bound. Hence only the molecules in the library that can be 
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sequenced are counted. (Meyer et al. 2008) However, this includes the conjoined primers 
and hence these primer dimers are indistinguishable from the sample library.  
 
Cluster amplification 
 
Sequencing takes place in a microarray surface called flow cell (Fuller et al. 2009). Flow 
cells have 8 individual lanes which enables running 8 physically separated DNA libraries 
(Mardis 2008). The sample library is hybridized to oligonucleotide adapters on the flow 
cell surface and clonally amplified before sequencing. 
 
Each DNA fragment that has the ability to be cluster amplified has adapters 
complementary to those in the flow cell surface in both ends of the fragment (Linnarsson 
2010, Pettersson, Lundeberg & Ahmadian 2009, Ansorge 2009). Adapters within flow 
cell are covalently bound to the flow cell surface (Mardis 2008). DNA molecules of a 
sample library are hybridized to the probes on the flow cell from 3’ end of the fragment 
and the 5’ end of the fragment is attached to an adapter complementary to this end of the 
fragment creating a bridge- like structure. Fragments are being amplified with a method 
called bridge amplification to generate clusters containing identical copies of the original 
molecule (Pettersson, Lundeberg & Ahmadian 2009, Ansorge 2009). This step is needed 
in order to detect the signal with CCD camera (Fuller et al. 2009). One flow cell contains 
hundreds of millions of these clusters in random positions, each cluster containing 
approximately 1000 copies of one clonal DNA fragment (Pettersson, Lundeberg & 
Ahmadian 2009). After cluster generation the flow cell contains heterogeneous 
population of clusters as each cluster contains clonal copies of one fragment (Illumina 
2010). (Figure 5) 
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Figure 5 Cluster amplification workflow. DNA is hybridized to the oligonucleotides on the surface of the 
flow cell. Single molecules are then amplified to generate clusters. Each cluster consists of identical copies  of the 
original template. (Adapted from “Go where biology takes you” brochure, http://www.illumina.com, 
Publication Number 770-2009-034) 
 
Sequencing 
 
Illumina Genome Analyzer II sequencing is based on sequencing-by-synthesis method in 
which fluorescent labelled, reversible terminated nucleotides are incorporated in a cyclic 
manner (Ansorge 2009). 
 
After the cluster amplification the fragments are linearized and sequencing primers are 
added (Illumina 2010). Sequencing is performed in cyclic manner. Each cycle consist of 
addition of polymerase and fluorescently labelled nucleotides with chemically 
inactivated 3’-OH (Mardis 2008), incorporation of the reversibly terminated nucleotide, 
washing of excess reagents, imaging of the flow cell to determine the incorporated 
nucleotide and finally removing fluorescent dye and blocking group from the 3’-end of 
the base (Mardis 2008, Ansorge 2009). These cycles are repeated up to 100 times.  
(Figure 6) Library molecules can also be sequenced from the other end of the molecule 
which results in 2 times more data. The paired reads facilitate the alignment of the short 
reads to genome and enable more specific mapping of fragments to the reference. These 
paired-end reads also enable detection of structural rearrangements (Tucker, Marra & 
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Friedman 2009). Over 20 gigabases of sequence can be generated with Genome Analyzer 
II in a paired-end sequencing run with 100 cycles (Illumina 2010). 
 
 
Figure 6 Sequencing-by-synthesis workflow. After the addition of reversible terminated base the flow 
cell surface is washed and imaged. The fluorescent dye and blocking agent is then removed and next base is 
added. These cycles can be repeated up to 100 times. (Adapted from “Go where biology takes you” brochure, 
http://www.illumina.com, Publication Number 770-2009-034) 
 
Data analysis 
 
The raw data from a sequencing run is images illustrating clusters after each cycle in 
each tile of the lane. Four images are taken per cycle for each tile, one for each 
nucleotide. The images are converted to sequence using Sequencing Control Software 
real time analysis (RTA) (Illumina). RTA defines bases on the basis of cluster intensities 
and noise estimates in a process called base calling. Up to 10 gigabases of sequence can 
be produced on one flow cell with a paired-end sequencing run with 50 basepairs read 
length (Illumina). The produced sequences can then be aligned to a reference sequence 
using CASAVA GERALD module (Illumina 2010). Alignment and further analyses can 
also be done with third party software, such as Burrows-Wheeler Aligner (BWA) (Li, 
Durbin 2009). 
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Aims of the study 
 
The protocols provided by instrument manufacturers and application providers are not 
fully optimized and protocols from different manufacturers have different approaches for 
sample preparation. This leads to the need for optimized and standardized protocol. An 
important aspect for a sample preparation protocol is sufficient quality control steps 
which are needed in troubleshooting and also when deciding whether to continue with a 
sample or not.  
 
The aim of this Master’s thesis was to find optimal sample preparation protocol which 
would lead to more uniform and higher data acquisition from sequencing with lower 
costs (Table 1). Methods optimized were DNA quantification and purification for sample 
amounts sufficient for sequence capture.  The purification optimization concentrates on 
finding a method which is capable of purifying enzymes and other reagents that might 
interfere the following sample preparation steps but also able to to purify primer dimers 
after PCR and preferably is size selective to fragment sizes from 150 to 500 base pairs. 
The fragmentation parameters for sonication were also tested. 
The aim was not to do basic research but rather to streamline production scale laboratory 
process.  
Table 1 Aims of this Master’s thesis. 
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Materials and methods 
 
Several types of sample material, including human and bacterial DNA, were used for 
constructing paired-end sample libraries as a part of ongoing projects. All libraries were 
constructed using NEBNext DNA sample preparation kits (New England Biolabs). The 
oligonucleotides in adapters and PCR primers were custom made by Sigma-Aldrich (St. 
Louis, MO, USA) according to sequence information provided by Illumina (Appendix 1). 
The tests conducted are listed in Table 2. 
 
Table 2 List of tests conducted with the series number. 
 
 
Fragmentation 
 
Bacterial and human genomic DNA from ongoing projects was fragmented with Covaris 
S2 –instrument with Snap-Cap microTube with AFA fiber and pre-split silicone septa 
(Covaris Inc). All samples were diluted in distilled water (Sigma Aldrich). Each test was 
conducted with only one fragmentation method per sample. Concentrations were 
measured with NanoDrop ND-1000 (Thermo Scientific, Wilmington, DE, USA). After 
the fragmentation the samples were purified with QIAquick PCR purification column 
(Qiagen, Venlo, The Netherlands) and one microlitre of each sample mixed with 4 
microlitres of FlashGel loading dye was run in a 2,2% FlashGel (Lonza, Basel, 
Switzerland) according to the protocol (Appendix 2). FlashGel DNA Quant Ladder 100-
1500 bp was used to determine the fragment sizes in concentration and time test and for 
Covaris protocols the FlashGel DNA Marker 100-4000 bp was used.  
Aim Series
Evaluate current fragmentation protocols A
Test the effect of the fragmentation length to product size B
Test the effect of concentration to product size C
Test the ability of purification methods to remove small fragments D
Evaluate the efficiency of purification methods to remove primer dimers E
Test the ability of purification methods to remove small fragments from sequencing library F
Compare the ability of current purification method and beads to enrich optimal fragment sizes G
Quantification Compare qPCR and Bioanalyzer for library quantification
Amplification Test how amplification cycles effects the artefact production and find optimal cycle number
Fragmentation
Purification
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The evaluation of the current protocols using Covaris fragmentation (Series A) 
 
The Covaris protocols for target base pair peaks of 200, 300, 500 and 700 were tested 
with a human genomic DNA sample with the sample volume of 120 microlitres and 
concentration of 25 nanograms per microlitre and 3000 nanograms of DNA in total.  
 
The effect of the fragmentation length to product size (Series B) 
 
In time change test (Series B) 3000 nanograms of human and bacterial DNA was 
fragmented according to Covaris protocol (Appendix 2 and 3) for target peak of 200 base 
pairs which is the current protocol in SureSelect Target Enrichment System (Appendix 
2). Fragmentation times of 90, 180 and 270 seconds were used. Sample volume was 100 
microlitres. 
 
The effect of the concentration in fragmentation to product size (Series C) 
 
In dose dependence test bacterial DNA was sufficient for sample amounts o f 1500 and 
3000 nanograms and human DNA for 1500, 3000 and 4500 nanograms. Sample volume 
was 120 microlitres due to a Covaris protocol change during these tests. The DNA was 
fragmented according to Covaris protocol for target peak of 200 base pairs with the 
fragmentation time of 180 seconds. 
 
Purification 
 
PCR purification was tested with two different human DNA libraries with high 
concentration of primer dimers and a low molecular weight DNA ladder. Each test was 
conducted with one purification per method. Series D, E and F were run with 
Bioanalyzer High Sensitivity kit after the purifications and Series G with DNA 1000 kit. 
The results were exported to Microsoft Office Excel (Microsoft, Redmond, WA, USA) 
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and cut-off size of 200 base pairs was defined in order to sort out primer dimers from 
sample library. 
 
The ability of purification methods to remove small fragments (Series D) 
 
Low Molecular Weight DNA Ladder (New England Biolabs) was diluted to 500 
picograms per microlitre. This sample was purified with QIAquick PCR purification 
column (Qiagen), Performa DTR (dye terminator removal) gel filtration cartridge with 
and without SOPE resin (EdgeBio, Gaithersburg, MD, USA), NucleoSpin Extract 
(Macherey-Nagel, Düren, Germany) and Agencourt AMPure XP SPRI beads (Beckman 
Coulter Genomics, Brea, CA, USA). The control for this purification test was the DNA 
ladder before purification (Figure 7). 
 
 
Figure 7 Bioanalyzer electropherogram illustrating DNA ladder before purifications. 
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The efficiency of purification methods to remove primer dimers (Series E) 
 
One of the DNA libraries was purpose-made for testing the purification. This library was 
constructed from human DNA according to SureSelect Target Enrichment protocol from 
Agilent with the exception of using 100 picomoles of primers instead of the 25 picomoles 
used in the SureSelect protocol in order to create excess primer dimers. Six parallel PCR 
reactions with ten amplification cycles were performed to obtain sufficient amount of 
sample for five different purifications. After the PCR the six reactions were pooled and 
then evenly divided to five aliquots, one for each purification method tested. The 
purification methods tested with this sample were QIAquick PCR purification column, 
Performa DTR Gel Filtration Cartridges with and without SOPE Resin (EdgeBio), 
NucleoSpin Extract II columns (Macherey-Nagel) and Agencourt AMPure XP SPRI 
beads (Beckman Coulter Genomics). The purifications were performed according to 
manufacturer’s protocols (Appendix 2). The control for this purification test was the 
QIAquick purification as it is the standard purification method in the Illumina, Agilent 
and Nimblegen sample preparation protocols. The sample preparation steps were done 
with NEBNext DNA Sample Prep Master Mix Set 1 (New England Biolabs).  
 
The ability of purification methods to remove excess amount of primer dimers from 
sequencing library (Series F) 
 
The libraries were constructed with NEBNext DNA Sample Prep Master Mix Set 1 and 
the capture was performed according to SureSelect Target Enrichment protocol.  The 
libraries from this pool were purified after 10 cycles of PCR according to SureSelect 
protocol with QIAquick PCR purification column. 24 microlitres of each of these 
libraries were pooled and diluted in molecular grade water to obtain adequate amount 
and volume of sample for three different purification methods. The primer dimers are 
shown in Figure 8. The purification methods used with this sample were NucleoSpin 
Extract II, Performa DTR Gel Filtration cartridge with SOPE resin and Agencourt 
AMPure XP SPRI beads (Beckman Coulter Genomics). The samples were purified 
according to the protocols (Appendix 2). The control for this test was the pool of Qiagen 
PCR purification column purified samples before other purifications. The QIAquick 
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purified sample and the NucleoSpin Extract II –purified sample were eluted in 50 
microlitres of 10 nanomolar Tris-HCl (pH 8) as the Agencourt AMPure XP SPRI bead –
purified sample was eluted in 100 microlitres of molecular biology grade water.  
 
 
Figure 8 Bioanalyzer Electropherogram illustrating  high concentration of primer dimers in a sample 
library before purification. 
 
Comparison of the ability of purification methods to enrich optimal fragment sizes (Series 
G) 
 
The Series A sample with target peak of 200 was purified with QIAquick PCR 
purification column after end repair with NEBNext DNA Sample Prep Master Mix Set 1.  
The sample was then purified with Agencourt AMPure XP SPRI beads following with 
A-tailing and ligation. After each step sample was purified with SPRI beads and after the 
purifications the sample was run with Agilent Bioanalyzer DNA 1000 kit. The SPRI bead 
purified sample after end repair was compared to the end repaired sample that was 
purified with QIAquick. Also the size distributions after each SPRI bead purification 
were compared. 
Amplification 
Primer 
dimers 
Library 
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The Series G sample with target peak of 200 base pairs after ligation was amplified 
according to thermal amplification protocol shown in Appendix 4. The samples were 
purified according to QIAquick PCR purification protocol and ran in Agilent Bioanalyzer 
DNA 1000 kit. 
 
Quantification 
 
Libraries from ongoing projects were used in quantification tests. Samples were 
quantified with qPCR and Bioanalyzer High Sensitivity kit. Libraries were prepared 
according to SureSelect Human All Exon protocol (Agilent) and SeqCap EZ exome 
protocol (Roche Nimblegen, Madison, WI, USA) (Appendix 2). Standard curve was a 2-
fold dilution series of a genomic human paired-end library prepared according to Agilent 
SureSelect protocol. Both the samples and the standard curve were prepared with 
NEBNext DNA Sample Prep Master Mix Set 1.  
 
qPCR reactions were run with 10 picomoles of primers complementary to the PCR tails 
in the ends of the fragments (Appendix 1) using DyNAmo HS SYBR Green (Finnzymes, 
Espoo, Finland). Amplification was run according to Finnzymes protocol (Appendix 2) 
with LightCycler 480 Real-Time PCR System (Roche, Penzberg, Germany). Both the 
standard and the libraries were diluted to 10 nanomoles per litre concentration. 
Concentrations were then verified with Bioanalyzer High Sensitivity kit. A dilution series 
of 100, 50, 25, 12,5, 6,25, 3,12 and 1,56 picomoles per litre was made from the standard 
sample. 500-fold dilution was made from the 10 nanomoles per litre concentration 
sample libraries. One microlitre of each standard curve and samples were used in each 20 
microlitre reaction in triplicates. The data was analyzed with LightCycler480 software 
(Roche) and exported to Excel.  
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Samples diluted to approximately 10 nanomoles per litre according to Bioanalyzer DNA 
1000 kit were also quantified with Bioanalyzer High Sensitivity kit according to 
protocol. 
 
The qPCR concentration was compared to the concentration obtained from Bioanalyzer. 
The Bioanalyzer results were used for determining the amount of library required for 
sequencing. The amount of library used for sequencing according to qPCR was also 
retraced and both methods were compared to the number of clusters in sequencing. 
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Results 
 
Fragmentation 
 
The evaluation of the current protocols using Covaris fragmentation (Series A) 
 
The purpose of the Covaris protocol test was to evaluate the fragment size distributions 
produced with the protocols provided by the manufacturer. This will further help to 
optimize the fragmentation for longer sequencing reads. The main difference in the 
protocols was that as the target base pair increases the duty cycle, intensity and 
fragmentation time decreases (Appendix 3). 
 
Samples fragmented according to Covaris protocol (Appendix 2) produced fragments 
that corresponds the target peaks given in the Covaris protocol (Table 3). Protocol for 
target peak of 200 base pairs however produced fragments with an average more c lose to 
250 base pairs than 200 as is shown in Figure 9.  
 
Figure 9 FlashGel after fragmentation with Covaris protocols. In lane 1 is human DNA before 
fragmentation. In lanes 2 to 5 are fragmented human DNA samples. In lane 2 sample fragmented with Covaris 
protocol with target peak 200 base pairs, lane 3 target peak 300, lane 4 target peak 500 and lane 5 target peak 
700. 
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Table 3 Fragment sizes after Covaris protocol fragmentations. All of the protocols produced average 
fragment sizes equivalent to protocol.
 
 
The effect of the fragmentation length to product size (Series B) 
 
Some DNA samples fragmented differently from most of the samples. Fragmentations 
with different time lengths were tested in order to be able to adjust the fragmentation for 
these samples. 
 
Human and bacterial samples have similar results. After 90 seconds treatment the 
fragment sizes vary from less than 100 base pairs to approximately 1500 base pairs. The 
majority of the fragments were in the size range from 300 to 600 base pairs. The default 
fragmentation time of 180 seconds and 270 seconds produces similar fragments with the 
mean size of 150 to 400 base pairs (Table 4). The 270 seconds produces only slightly 
smaller fragments than 180 seconds. (Figure 10) 
 
Sample Target Peak
Minimum 
fragment 
size
Mazimum 
fragment 
size
Average 
fragment 
size
Equivalent 
to average 
base pairs 
given in 
protocol
200 bp 150 600 250 Yes
300 bp 175 900 300 Yes
500 bp 190 1200 500 Yes
700 bp 190 1200 700 Yes
Human
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Figure 10 FlashGel after time test in fragmentation. Lane 1 is human DNA before fragmentation. Lanes 
2, 3 and 4 are human DNA after 90 (2), 180 (3) and 270 (4) seconds of fragmentation. Lanes 5, 6 and 7 are 
bacterial DNA after after 90 (5), 180 (6) and 270 (7) seconds of fragmentation. 
 
Table 4 Fragment sizes after time change test in fragmentation. After 90 seconds fragmentation the 
fragments are slightly above optimal as other fragmentation times produce optimal fragments. 
 
  
The effect of the concentration in fragmentation to product size (Series C) 
 
The purpose of the dose dependence test was to test the effect of 2-fold concentration 
changes to the fragmentation since the quantification methods show fluctuation between 
measurements and hence the concentrations between samples vary. This test will help to 
determine the accepted concentration range for fragmentation.   
 
Sample
Fragmentation 
time
Minimum 
fragment 
size
Mazimum 
fragment 
size
Average 
fragment 
size
Acceptable 
range
90 s <100 1500 500 Above 
180 s <100 800 300 Yes
270 s <100 800 200 Yes
90 s <100 1500 500 Above 
180 s <100 800 300 Yes
270 s <100 800 200 Yes
Human
Bacterial
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The concentration test revealed that increasing the concentration resulted in smaller 
fragment sizes. The fragment sizes vary from less than 100 base pairs to 800 base pairs in 
each concentration as is shown in Figure 11 and Table 5. The mean fragment sizes in the 
1500 nanogram samples were from 200 to 400 base pairs, in the 3000 nanogram samples 
from 150 to 300 base pairs and in 4500 nanogram sample from 100 to 200 base pairs. 
Human and bacterial samples have similar fragment size distributions and this suggests 
that the concentration of the starting material, rather than the size of the genome affect 
the fragmentation efficiency. 
 
Figure 11 FlashGel after DNA concentration test in fragmentation. In lane 1 is human DNA before 
fragmentation, lanes 2, 3 and 4 are human DNA with 1500 (2), 3000 (3) and 4500 (4) nanograms of starting 
material. Lanes 5 and 6 are bacterial DNA with 1500 (5) and 3000 (6) nanograms of starting material. 
 
Table 5 Fragment sizes after concentration change test in fragmentation. All concentrations produce 
fragment sizes optimal for sequencing 
 
 
Sample Amount of DNA
Minimum 
fragment 
size
Mazimum 
fragment 
size
Average 
fragment 
size
Acceptable 
range
1500 ng <100 800 300 Yes
3000 ng <100 700 175 Yes
4500 ng <100 600 150 Yes
1500 ng <100 800 300 Yes
3000 ng <100 700 175 Yes
Human
Bacterial
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Purification 
 
The purpose of the purification tests was to evaluate the different purification methods. 
The evaluation criteria were the capability to purify enzymes and other reagents, the 
ability to remove primer dimers and to have size selectivity from 200 base pairs to 500 
base pairs. The removal of the primer dimers enables more precise quantification. As the 
read lengths grow, it is important to exclude fragment sizes less than the read length as 
the current  analysis algorithms discards the reads that have been read through and also 
as part of the paired-end sequencing capacity is lost if the paired-end reads overlap. 
Current protocols either use size selection from gel to prevent this or ignore the issue. As 
the size selection improves the sequencing yields and the gel selection is laborious the 
ability of purification methods to discard fragment sizes under 200 base pairs was also 
evaluated in order to improve the library preparation. 
 
The ability of purification methods to remove small fragments (Series D) 
 
To evaluate the capability of different purification methods to remove fragment sizes less 
than 200 base pairs a DNA size marker was purified with NucleoSpin Extract II, 
Performa DTR with and without resin, AMPure XP beads and QIAquick column. 
 
As is shown in Figure 13, Performa DTR with resin and Agencourt AMPure XP SPRI 
beads have the highest proportional yield of fragment sizes larger than 200 base pairs as 
Performa DTR without resin purifies more efficiently the larger fragments. QIAquick 
purifies only slightly more the smaller fragments than the larger ones. The purification 
efficiencies are also illustrated in Bioanalyzer electropherograms in Figure 14. 
 
NucleoSpin Extract II column gave highest DNA yield after purification with 86 per cent 
yield (Table 6). Also Performa DTR without resin (83%), AMPure XP beads (81%) and 
QIAquick (82%) gave good yields. The yield with Performa DTR with resin was less 
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than half of the starting material as is shown in Figure 14. Non-purified DNA marker was 
used as a control. 
 
Table 6 Table representing the data from DNA marker purification.  
 
 
 
Figure 12 DNA yield after purification in DNA marker test. Yields with all purification methods are good 
except with the Performa DTR with resin.  
  
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
154,66 204,75 136,49 162,2 48,86 108,47 113,34 182,25 119,77 189,29 101,21 189,57
Yield pg/µl
Yield from 
control
Per cent from 
control 100 % 100 % 88 % 79 % 32 % 53 % 73 % 89 % 77 % 92 % 65 % 93 %
Per cent of 
larger than 200 
bp fragments
359,41 298,69 157,33 295,59
Control Performa DTR 
Performa DTR 
with Resin QIAquick
NucleoSpin 
Extract II
61,2 % 65,2 %
100 % 83 % 44 % 82 %
57,0 % 54,3 % 68,9 % 61,7 %
AMPure XP SPRI 
beads
309,06 290,78
86 % 81 %
100 %
83 %
44 %
82 %
86 %
81 %
0 %
20 %
40 %
60 %
80 %
100 %
120 %
Control Performa DTR Performa DTR 
with Resin 
QIAquick NucleoSpin 
Extract II
AMPure XP 
SPRI beads
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Figure 13 The ratio of smaller and larger than 200 base pair fragments after purification in DNA marker 
test. Performa DTR without resin purifies larger fragments more efficiently than smaller. Other purification 
methods purify smaller fragment more efficiently than larger fragments. From these AMPure XP SPRI beads 
and Performa DTR with resin most efficiently. 
 
 
Figure 14 Bioanalyzer electropherogram illustrating the difference between DNA ladder before 
purification (red) and after purification with the purification method (blue). Uppermost electropherogram (1) 
illustrates the QIAQuick column purification, 2 purification with Performa DTR, 3 Performa DTR with resin, 4 
Nucleospin Extract II and 5 Agencourt AMPure XP SPRI beads. Performa DTR with resin removes the small 
fragments most efficiently. 
  
  
Control
Performa 
DTR 
Performa 
DTR with 
Resin 
QIAquick
NucleoSpi
n Extract 
II
AMPure 
XP SPRI 
beads
Smaller than 200 bp 100 % 88 % 32 % 73 % 77 % 65 %
Larger than 200 bp 100 % 79 % 53 % 89 % 92 % 93 %
0 %
20 %
40 %
60 %
80 %
100 %
120 %
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The efficiency of purification methods to remove primer dimers (Series E) 
 
The purpose-made library was a sample library amplified with the excess of primers in 
order to obtain a library with primer dimers. The purpose of purifying this library was to 
evaluate the efficiency of different purification methods to remove primer dimers. 
 
The QIAquick column purification results were used as a control in the purpose-made 
library purification test since the QIAquick is the standard purification method and non-
purified sample would not have been good control since the reagents might have had 
impact in the Bioanalyzer run.  
 
All the purification methods except Performa DTR without resin purify the smaller 
fragments more efficiently than QIAquick. From these NucleoSpin Extract has the best 
overall yield (Table 7). Performa DTR without resin gave the highest yield (Figure 15) 
but most of the yield was fragments smaller than 200 base pairs (Figure 16) thus meaning 
that Performa DTR is purifying relatively more of the sample library than the primer 
dimers. 
  
The Bioanalyzer electropherograms in Figure 17 illustrates the purification efficiencies in 
which the NucleoSpin Extract II purifies the primer dimers most efficiently.  
Table 7 Table representing the data from purpose-made library purification. 
 
 
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
4752,7 11286,77 16089,53 6466,43 1851,47 7906,45 2298,52 11894,46 1585,46 11655,59
Yield pg/µl
Yield from control
Per cent from 
control 100 % 100 % 339 % 57 % 39 % 70 % 48 % 105 % 33 % 103 %
Per cent of larger 
than 200 bp 
fragments
14192,98
141 % 61 %100 % 88 %
Agencourt AMPure 
XP SPRI beads
13241,05
83 %
88 %
Control
Performa DTR
Performa DTR with 
resinQIAquick NucleoSpin Extract II
29 % 81 %70 % 84 %
22555,96 9757,9216039,47
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Figure 15 DNA yield after purification in purpose-made sample library test. Performa DTR without 
resin has the highest yield and Performa DTR with resin the lowest. NucleoSpin Extract II and AMPure XP 
SPRI beads both have good yield. 
 
 
Figure 16 The ratio of smaller and larger than 200 bp fragments after purification in purpose -made 
library test. Performa DTR without resin purifies larger fragments more efficiently than smaller. Other 
purification methods purify smaller fragment more efficiently than larger fragments. From these AMPure XP 
SPRI beads most efficiently. 
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Figure 17 Bioanalyzer electropherograms illustrating the purpose-made sample after the purifications 
with Qiaquick (1), Performa DTR (2), Performa DTR with resin (3), NucleoSpin Extract II (4) and Agencourt 
AMPure XP SPRI beads (5). Red arrow indicates the primer dimers. Blue arrow indicates the lower marker 
with size of 35 base pairs and violet arrow points the upper marker with the size of 10380 base pairs. 
 
The ability of purification methods to remove excess amount of primer dimers from 
sequencing library (Series F) 
 
The Bioanalyzer electropherograms from the sample pool after purifications shows that 
all the methods tested with this sample removed the primer dimers (Figure 18, 20). From 
these the NucleoSpin Extract II columns and Agencourt AMPure XP SPRI beads have 
the highest yield (Figure 19, Table 8).  
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Figure 18 Overlay of Bioanalyzer electropherograms of sample pool purification test. NucleoSpin Extract 
II (Blue) and SPRI beads (green) gave the highest yields but Performa DTR cartridges (red) also removed the 
primer dimers but with lower yield. 
 
Table 8 Table representing the data from sample library pool purification. 
 
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Smaller 
than 200 
bp
Larger 
than 200 
bp
Yield   318,65 4467,88 0 1383,24 0 4416,16 0 2226,95
Yield pg/µl
Yield from 
control
Yield from 
control 100 % 100 % 0 % 31 % 0 % 99 % 0 % 100 %
Per cent of larger 
than 200 bp 
fragments 93 % 100 % 100 % 100 %
4786,53 4416,16
100 % 29 % 92 % 93 %
Control
QIAquick
Performa DTR with 
Resin
NucleoSpin Extract 
II AMPure SPRI beads
1383,24 2226,95
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Figure 19 DNA yield after purification in project sample pool test. Performa DTR with resin gave the 
lowest yield as NucleoSpin Extract II and AMPure XP SPRI beads both gave high yields. 
 
Figure 20 The ratio of smaller and larger than 200 bp fragments after purification in project sample pool 
test. All of the tested purification methods removed the small fragments. 
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Comparison of the ability of purification methods to enrich optimal fragment sizes (Series 
G) 
 
The purpose of the Agencourt AMPure XP SPRI bead test was to test the size selectivity 
of the beads compared to the QIAquick column. The test sample was normal sequencing 
library. The SPRI bead size selection test reveals that SPRI beads enriches for the 
fragments sizes larger than 100 base pairs as QIAquick removes all fragment sizes 
equally (Figure 21). However, SPRI beads have lower yield in all fragment sizes.  
 
 
Figure 21 Covaris sample with target peak 200 after QIAquick (blue) and SPRI bead (red) purifications. 
SPRI beads have lower overall yield than Qiaquick but SPRI beads have size selectivity to optimal fragment 
sizes. 
 
The SPRI bead purification after each sample preparation step narrowed the library 
which can be concluded from the diminishing standard deviation after each consecutive 
SPRI bead purification (Table 9). This can be seen also in the Bioanalyzer overlay of 
each step (Figure 22).  
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Figure 22 SPRI bead purifications after end repair (red), A-tailing (blue) and ligation (green). The size 
shift after ligation is due to the addition of the adapters to the ends of the fragments. 
 
Table 9 Concentrations of different fragment sizes after each consecutive SPRI bead purification. 
Target fragment sizes are highlighted in green. 
 
From 
[bp] To [bp]
After end 
repair (first 
SPRI bead 
purification
After A-
tailing 
(second 
SPRI bead 
purification
After 
ligation 
(third SPRI 
bead 
purification
50 100 2 % 0 % 0 %
100 150 15 % 13 % 3 %
150 200 19 % 21 % 11 %
200 250 18 % 19 % 18 %
250 300 16 % 16 % 20 %
300 350 11 % 11 % 15 %
350 400 8 % 8 % 12 %
400 450 4 % 4 % 7 %
450 500 3 % 3 % 5 %
500 550 1 % 2 % 3 %
550 600 1 % 1 % 3 %
600 650 1 % 1 % 2 %
650 700 0 % 0 % 1 %
700 750 0 % 0 % 0 %
750 800 0 % 0 % 0 %
800 850 0 % 0 % 0 %
850 900 0 % 0 % 0 %
900 950 0 % 0 % 0 %
950 1 000 0 % 0 % 0 %
2,49 1,99 1,17
Concentration
Standard deviation
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Quantification 
 
Concentrations measured by qPCR were repeatedly lower than those measured with 
Bioanalyzer except for two individual samples. This is expected since qPCR counts only 
the molecules that have adapters ligated to both ends and are thus able to amplify in the 
flow cell while Bioanalyzer measures all the double stranded DNA fragments.  
 
The average difference between qPCR and Bioanalyzer was 2,01 nanomoles per litre as 
the median was 2,43 and standard deviation was 2,12. These values are quite high but as 
the methods measures different molecules the values are tolerable. Concentrations from 
both methods are illustrated in Figure 23. The number of sequencing clusters better 
correlates with qPCR than Bioanalyzer (Figure 24) with the R2 value of 0,628 and 0,1765 
respectively. 
 
 
Figure 23 Library concentrations measured with qPCR (purple) and Bioanalyzer (blue). The 
concentrations measured with qPCR are repeatedly lower than those from Bioanalyzer. 
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Figure 24 Clusters generated per tile according to qPCR (red) and Bioanalyzer (blue). The correlation 
between concentration and clusters are higher with qPCR than Bioanalyzer. 
 
Amplification 
 
The libraries must be amplified in order to produce sequence to the ends of the molecules 
which enable the attachment of the fragment to the flow cell. Amplification is also 
needed in order to produce sufficient amount of DNA to the capture. The amplification 
takes place after the ligation as the amplification primers are complementary to the 
adapters. Recent studies also suggest that transcriptome sequencing is possible without 
amplification (Mamanova et al. 2010a). This creates further interest in studying 
amplification free library preparation methods.  
 
The amplification test shows that using fewer cycles, less material will be produced but 
also using too many cycles will produce amplification artefacts that are conjoined 
fragments and are shown in a Bioanalyzer electropherogram as a second peak with the 
fragment size double the original. The artefacts begin to form after 16 cycles of 
amplification and in Figure 27 this can be seen as the change in the electropherogram 
profile. In Figure 28 which illustrates the sample after 20 cycles of amplification the 
second peak is evident.  
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The concentration after amplification and purification is highest after ten cycles with 
18,28 nanograms per microlitre as is shown in Figure 29. This is due to the reason that 
fragments starts to concatenate and form artefacts. This artefact formation should be 
avoided by using as few cycles as possible. Electropherogram of sample after 10 cycles 
in illustrated in Figure 26. Amplification with 6 cycles (Figure 25) has the lowest yield.  
 
 
Figure 25 Bioanalyzer electropherogram from human DNA library after 6 cycles of amplification. 
 
 
Figure 26 Bioanalyzer electropherogram from human DNA library after 10 cycles of amplification. 
 
 
Figure 27 Bioanalyzer electropherogram from human DNA library after 16 cycles of amplification. 
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Figure 28 Bioanalyzer electropherogram from human DNA library after 20 cycles of amplification. 
 
Figure 29 Concentrations of the purified samples after amplification with different cycles. 
 
The impact of the optimization to sequencing yields 
 
The overall library preparation costs have reduced one fifth due to the change of sample 
preparation kit. The purification method has been changed to Agencourt AMPure XP 
SPRI beads since they are easy to automate and are size selective without significant loss 
in sample material. The samples have more uniform performance in amplification and 
reduced amount of artefacts are produced. The Bioanalyzer will still be used in the 
sample preparation protocol for quantification and quality assessment, but the qPCR will 
be used for the quantification prior to sequencing. The sequencing yield has grown from 
the average of 550 megabases before optimization to an average of 930 megabases after 
optimization (Table 11). The yield has also become more uniform (Figure 30). The 
results and the alterations to the original protocol are represented also in Table 10.  
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Table 10 Alterations made to the original protocol and their affect.  
 
 
Figure 30 Yield (kbases) per lane before and after optimization. The yield is higher and more uniform 
after the optimization. 
 
Table 11 Average yield (kbases) per lane before and after optimization. 
  
Average lane yield 
(kbases) Std deviation 
Before optimization 546240 173708 
After optimization 933172 140286 
 
Step Original protocol Current protocol
Improvements to original 
protocol
Library 
preparation
Illumina Sample 
preparation kit
NEBNext DNA Sample 
Preparation kit Costs reduced to one fifth.
1) Purify enzymes and other 
reagents
2) Purify primer dimers
3) Size selective for fragments 
from 200 to 500 base pairs
4) Automatable
Known concentration of 
DNA to amplification.
Uniform performance between 
samples. 
 Lowered amplification 
cycles
Reduction of artefact production.
Quantification Bioanalyzer Bioanalyzer and qPCR
More uniform data yield from 
sequencing.
Amplification Unknown amount of 
sample to amplification. 
Fixed number of 
amplification cycles. 
Inconsistent behaviour 
between samples. 
Fragments 
concatenating, artefact 
formation.
Purification QIAquick PCR 
purification column
SPRI bead purification
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Discussion 
 
Since the DNA quantification methods for genomic DNA all have their defects and each 
method may give divergent concentration for one sample it was important to know how 
2-fold changes in DNA concentration effects the fragmentation. This study suggests that 
within 2-fold concentration range the fragments produced do not differ dramatically and 
all the libraries produced contained fragment sizes suitable for sequencing.  
 
As the fragmentation time increases the fragment sizes decrease. However, the change is 
not linear as halving and doubling the time does not have the same shift in the size. This 
information may be helpful in the future for optimizing protocols for challenging 
samples, that are difficult to fragment albeit having good purity and being intact before 
fragmentation. These challenging samples may be lost in fragmentation when the default 
fragmentation protocol is used, while some samples were not fragmented at all. These 
challenging samples are subject to future studies.  
 
The read lengths in sequencing with Illumina Genome Analyzer II have grown from 36 
base pairs to 100 base pairs. Additionally, instead of reading the sequence only from one 
end (single read), one can today read the fragments from both ends (paired end). This 
leads to the need for longer fragments in order not to sequence the insert through. This 
would mean gaining overlapping sequences in the middle of the sequence which would 
diminish the overall sequence gained. In the Covaris protocol test the fragment size 
distributions produced with the protocols provided by Covaris were tested. The produced 
fragment sizes corresponded the presumed target peaks. These protocols and the effect of 
the variables to the fragment size will be important information in the future as the 
sequencing reads lengthen. During this study the fragmentation protocol from target base 
pair of 200 has already grown to 300.  
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Another problem with small fragment sizes is the purification issue, since fragmentation 
methods covered in this thesis and mentioned in the introduction are also producing 
fragments smaller than the read length in sequencing. The main focus on purification 
tests in this thesis was to identify a method capable of removing primer dimers. The 
primer dimers interfere with the concentration measurement as they are also nucleic acid 
and for example qPCR is unable to distinguish primer dimers from the sample library. 
The primer dimers can be distinguished from the sample library with Bioanalyzer but as 
the primers are complementary to the adapters in the flow cell it is possible that these 
primers block the adapters which results to lower sequencing yield. The NucleoSpin 
Extract II and SPRI beads were found to most efficiently remove the primer dimers and 
still remain a good DNA yield. From these two the SPRI beads were selected as they are 
universally applicable to each step of the process, easy to automate and affordable.  
 
In the current protocols agarose gel selection is used for se lecting fragments sizes of 
interest. This is laborious, time consuming, results in a significant DNA loss and also 
introduces the possibility of contamination. Hence more efficient size selection methods 
were studied. Since the SPRI beads are size selective it was also tested how well the 
beads can produce sample library with tighter fragment distribution. The SPRI bead size 
selection test indicated that using SPRI beads to purify the sample after end repair, A-
tailing and ligation narrowed the fragment distribution, indicating removal of both small 
and large fragments. This is important for the reasons described earlier and also as 
smaller fragments are sequenced more efficiently due to more efficient cluster 
amplification of smaller fragments. However, the data analysis on the necessity of also 
removing the larger fragments is still ongoing.  
 
The DTR gel filtration cartridges were used in the purification tests instead of PCR 
purification cartridges as previous studies in the capillary sequencing group suggests that 
DTR cartridges with resin perform as well or even better than PCR purification 
cartridges. 
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As amplification is exponential it is important to use as few amplification cycles as 
possible but yet produce sufficient amount of sample for sequence capture and 
sequencing. In this thesis the threshold for amplification artefact production was 
determined. Other vital information would be the correlation between starting material, 
number of cycles and per cent of clonal molecules. The purpose of amplifica tion after 
library preparation is to enrich perfect fragments and to gain enough sample to be able to 
quantify it accurately for sequencing after sequence capture and not to produce clonal 
molecules. These clonal molecules are discarded in the primary sequencing data analysis 
as they do not provide any new information. Thus they lower the overall sequencing 
yield and hence it is important to use as few cycles as possible, and instead, prepare 
parallel reactions for each sample to prevent the production of c lonal molecules. This 
was not, however, studied in this thesis, but will be looked into in the future. Here the 
libraries from samples amplified with 10, 15 or 20 nanograms of DNA, using 8 to 10 
amplification cycles in 3 to 5 parallel reactions produced good quality sequence with 
negligible amount of clonal molecules. This is visualised in a screen shot from SeqMonk 
software (Babraham Institute, Cambridge, UK) which illustrates reads covering exons 
from EDNRB gene captured with Agilent and Nimblegen exome capture kits (Figure 
31). The samples were part of an ongoing project but not this thesis.  
 
Figure 31 Reads covering the exons of EDNRB gene captured with Agilent All Exon kit and Nimblegen 
EZ Exome kit (Courtesy of Dr Janna Saarela and Anna-Maija Sulonen). 
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In order to gain maximum data yield with good repeatability it is important to accurately 
quantify the library. This is due to the fact that if the concentration is too high clusters 
will overlap and reduced amount of data is acquired. If the concentration is too low the 
maximum sequencing capacity will be lost.  
 
The quantification test was only conducted with Bioanalyzer and qPCR as these were 
considered to produce more information on the sample. NanoDrop is unable to 
distinguish between substances absorbing UV light at the wavelength of 260 from DNA 
and hence it is not considered reliable method especially in low concentration (Gallagher 
SR & Desjardins PR 2008). 
 
Comparing the two DNA quantification methods showed that the DNA concentrations 
measured by qPCR were consistently lower than those from Bioanalyzer. qPCR only 
measures fragments that have adapters in both ends and are thus able to amplify in a flow 
cell. Bioanalyzer High Sensitivity kit has quantitation accuracy of 20% CV and qPCR 
protocol includes dilutions that produce pipetting variance. This explains the variation in 
the concentration differences between these two methods and also explains two samples 
in which the concentration was higher when measured with qPCR. Thus far the amount 
of DNA for sequencing has been measured with Bioanalyzer but as the qPCR has a better 
correlation to the number of clusters it should be considered as a default  method in the 
future. This results in even more uniform cluster numbers and reaches the highest 
possible cluster number. However, Bioanalyzer will still be used to determine the 
fragment distribution and the possible presence of primer dimers.  
 
Real-time PCR absolute quantification of genomic DNA could be possible with universal 
primers but this would require a standard sample with known concentration. This 
concentration would require quantification with another known method e.g. with 
NanoDrop and thus this method would be redundant. Hoechst stains which are 
fluorescent dyes could be used as another method for quantification of genomic DNA. 
These stains bind to double stranded DNA and the fluorescent emission can be measured 
with standard spectrofluorometer (Invitrogen 2010).  
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As a result of this Master’s thesis the sample preparation costs have reduced to one fifth 
of the original sample preparation process despite the fact that quality control steps ha ve 
been added to the protocol to ensure more uniform sample libraries. The quality control 
steps added are Bioanalyzer DNA 1000 verification of the library after end repair, 
ligation and amplification to ensure the addition of the adapters and PCR tails. In the 
Bioanalyzer this can be seen as a size shift with the size of adapters and PCR tails. This 
results in lower sequencing costs with higher quality. Since these data the Genome 
Analyzer II has been upgraded to IIx and the data yields are even higher.  
 
The sequencing starting from sample preparation was a slow process taking 
approximately three weeks from sample preparation to raw data acquisition for only a 
single sample. This was followed by data analysis which was the most time consuming 
part. The sequencing of one sequence captured sample costs almost 3000 euros. Thus the 
resources available for optimization, including time, funding and material, were limited. 
Since the aim of this study was to streamline production scale laboratory process the 
steps with the potential of immediate enhancement for sequencing quality were studied.  
 
Sequencing applications and methods are an important field of study that is continuously 
developing and new applications are coming to market all the time. At the time of 
finishing this Master’s thesis automated sample preparation instruments are about to 
come to market as well as kits that are automatable.  
 
Sample preparation method using novel and innovative approach has also come to 
market. Nextera (Epicentre Biotechnologies, Madison, WI, USA) technology is based on 
in vitro transposition in which transposon complex nicks both strands of the DNA and 
attaches transposon sequence to the nicked end (Syed, Grunenwald & Caruccio 2009). 
This method is equivalent to fragmentation, end repair and ligation in the conventional 
sample preparation but the construction of library with adapters in the ends with Nextera 
is significantly faster. The low amount of starting material (50 nanograms) and quick 
sample preparation makes it promising method in near future. Figure 32 illustrates the 
Nextera workflow. 
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Figure 32 Nextera transposition sample preparation overview. Target DNA  is  fragmented and  tagged 
with Nextera Enzyme Mix containing  transposon ends appended with  sequencing  primer  sites  (blue  and  
orange).    Limited-cycle  PCR  with  a  four-primer  reaction  adds bridge PCR  (bPCR)-compatible adaptors  
(purple and pink)  to  the core sequencing  library.  (Adapted from Nextera protocol, www. epibio.com)  
 
The latest sequencing instruments at the market such as HiSeq 2000 from Illumina is 
capable of sequencing two whole human genomes in a single run with less than $10.000 
per sample (Illumina 2010).  
 
The next application in sequencing will be single molecule sequencing. Several 
approaches have already been announced. Single molecule sequencing will reduce time 
expenditure and costs per nucleotide in sequencing as well as lowers the sample volumes 
(Treffer, Deckert 2010). It will also remove the need for amplification which introduces 
the risk of contamination and potentially creates biases (Fuller et al. 2009). 
 
Even as the platforms develop the need for high quality libraries still remain in order to 
have high quality data.  
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APPENDIX 1: Primer and adapter sequences 
 
APPENDIX 2: Protocols 
 
APPENDIX 3: Covaris Protocols 
 
 
  
Protocols Part number Reference
DNA Shearing with microTubes (<1.5kb fragments) 400056 http://www.covarisinc.com/
FlashGel® System 00521123-0209-01 http://www.lonza.com/
SureSelect Target Enrichment System Protocol G3360-90010 http://chem.agilent.com/
PCR clean-up Gel Extraction User Manual NucleoSpin® Extract II http://www.mn-net.com/
QIAquick® Spin Handbook http://www.qiagen.com/
Performa® DTR Gel Filtration Cartridges http://www.edgebio.com/
Agencourt® AMPure XP PCR purification 000387v001 http://beckmangenomics.com/
NimbleGen SeqCap EZ Exome Library SR User’s Guide 5987407001 http://www.nimblegen.com/
SureSelect Human All Exon Kit G3362-90001 http://chem.agilent.com/
DyNAmo™ HS SYBR® Green qPCR Kit http://www.finnzymes.com/
Temperature  6° to 8°C (chiller set to 4°C)
Target Base Pair (Peak)  200 * 300 500 700 Power mode  Frequency Sweeping  
Duty Cycle  10% 10% 5% 5% Degassing mode  Continuous 
Intensity  5 4 3 3 Volume    120 µl
Cycles per Burst  200 200 200 200 Buffer    Tris EDTA, pH 8.0 (no glycerol) 
Time (seconds)  180 120 90 75 Mass (DNA)  <3µg/100 µl 
*  Protocol used in SureSelect Target Enrichment protocol Water level (RUN)  S2 
‐
 level 12 (E210 
‐
 level  6) 
COVARIS PROTOCOLS (Part number 400056 )
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APPENDIX4: Thermal amplification protocol 
 
PCR Master Mix 1x 
Final amount of 
substance 
Phusion High-Fidelity PCR Master mix  25 µl   
PCR Primer Forward (20 µM 1,2 µl 24 picomoles 
PCR Primer Reverse (20 µM) 1,2 µl 24 picomoles 
Water X   
DNA 15 ng 15 ng 
Volume 50 µl   
 
Termal cycling  
 
Step Temperature Time 
1 98 °C 2 min 
2 98 °C 20 s 
3 65 °C 30 s 
4 72 °C 30 s 
5 go to step 2 X more times 
6 72 °C 5 min 
7 10 °C forever 
 
 
 
 
